Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Shanghai Pulmonary Hospital, Shanghai, China
University of Texas Southwestern Medical Center
Washington University School of Medicine
Eastern Cooperative Oncology Group
Stanford University
Franciscus Gasthuis & Vlietland (Hospital)
Peking University People's Hospital
Stanford University
Cedars-Sinai Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Memorial Sloan Kettering Cancer Center
Ohio State University Comprehensive Cancer Center
University of Chicago
Ohio State University Comprehensive Cancer Center
Haukeland University Hospital
Alliance for Clinical Trials in Oncology
CairnSurgical, Inc.
The Netherlands Cancer Institute
Seoul St. Mary's Hospital
Mayo Clinic
Cedars-Sinai Medical Center
Chinese University of Hong Kong
Shanghai Pulmonary Hospital, Shanghai, China
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Hospital do Coracao
Peking University Cancer Hospital & Institute
Northwestern University
Yale University
Seoul National University Hospital
Northwestern University
Istanbul University - Cerrahpasa
Fudan University
Fudan University
Indiana University
Radboud University Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
The First Affiliated Hospital with Nanjing Medical University
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Columbia University
Fujian Medical University Union Hospital
Fujian Medical University Union Hospital
Xuanwu Hospital, Beijing
The Netherlands Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
University of Virginia
Brown University
Sisli Hamidiye Etfal Training and Research Hospital